Literature DB >> 24743908

Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis.

Shorook Na'ara1, Moran Amit, Salem Billan, Jacob T Cohen, Ziv Gil.   

Abstract

BACKGROUND: The common treatment of primary patients with nasopharyngeal carcinoma is chemotherapy and radiotherapy. Surgery is reserved as salvage procedure for recurrent or persistent disease. Nevertheless, information on the outcome of these patients and the role of adjuvant reirradiation treatment is scarce.
METHODS: We conducted a meta-analysis to identify prognostic factors associated with outcomes of patients with recurrent nasopharyngeal carcinoma treated by salvage surgery.
RESULTS: The study group consisted of 779 patients from 17 published studies who met the inclusion criteria. The primary tumor classification at recurrence was T1-2 in 83 % of patients and T3-4 in 16.6 %. Regional lymph node metastases were present in 88 patients. The 5-year overall survival and local recurrence-free survival rates of the entire cohort were 51.2 and 63.4 %, respectively, with a distant metastases rate of 11.3 %. The 5-year overall survival was 63 % in patients receiving surgery and adjuvant radiotherapy compared to 39 % in patients receiving surgery alone (P = 0.05). Independent predictors of outcome on multivariate analysis were sex, N classification, surgical approach (endoscopic vs. open), adjuvant treatment, and margin status. Both endoscopic surgery and reirradiation were independent predictors of improved survival.
CONCLUSIONS: More than half of the patients with recurrent disease can be salvaged by surgery. Margins status, and N and T classification are significant predictors of outcome. Multivariate analysis revealed that endoscopic surgery offers better outcome than open surgery for T3/4 disease in selected patients, and adjuvant reirradiation offers an additional survival advantage over surgery alone.

Entities:  

Mesh:

Year:  2014        PMID: 24743908     DOI: 10.1245/s10434-014-3683-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience.

Authors:  Juan Liu; Huapeng Yu; Xicai Sun; Dehui Wang; Yurong Gu; Quan Liu; Huan Wang; Wade Han; Allison Fry
Journal:  Int J Clin Oncol       Date:  2017-06-10       Impact factor: 3.402

2.  Outcomes of Recurrent Nasopharyngeal Carcinoma Patients Treated With Salvage Surgery: A Meta-Analysis.

Authors:  Yekai Feng; Zhimei Dai; Ruicheng Yan; Feng Li; Xiaosheng Zhong; Haoxin Ye; Caiqing Chen; Shaochong Fan; Cheng Qing; Yong Pan; Haiying Sun
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

3.  Real time near-infrared Raman spectroscopy for the diagnosis of nasopharyngeal cancer.

Authors:  Lim Chwee Ming; Nagaraja Rao Gangodu; Thomas Loh; Wei Zheng; Jianfeng Wang; Kan Lin; Huang Zhiwei
Journal:  Oncotarget       Date:  2017-07-25

4.  Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.

Authors:  You-Ping Liu; Xing Lv; Xiong Zou; Yi-Jun Hua; Rui You; Qi Yang; Le Xia; Shao-Yan Guo; Wen Hu; Meng-Xia Zhang; Si-Yuan Chen; Mei Lin; Yu-Long Xie; Li-Zhi Liu; Rui Sun; Pei-Yu Huang; Wei Fan; Xiang Guo; Ming-Huang Hong; Ming-Yuan Chen
Journal:  Cancer Commun (Lond)       Date:  2019-11-15

Review 5.  Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.

Authors:  Michaela Svajdova; Marian Sicak; Pavol Dubinsky; Marek Slavik; Pavel Slampa; Tomas Kazda
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

6.  SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

Authors:  Antonio Rueda Domínguez; Beatriz Cirauqui; Almudena García Castaño; Ruth Alvarez Cabellos; Alberto Carral Maseda; Beatriz Castelo Fernández; Leticia Iglesias Rey; Jordi Rubió-Casadevall; Virginia Arrazubi; Ricard Mesía
Journal:  Clin Transl Oncol       Date:  2022-03-18       Impact factor: 3.405

7.  A combined microinvasive trans-submandibular and nasendoscopy surgical approach to dissect recurrent or radiotherapy-insensitive nasopharyngeal carcinoma.

Authors:  Yanming Zhao; Jugao Fang; Qi Zhong; Luo Zhang; Chengsuo Wang; Jiamin Zhang; Jiaming Chen; Ling Feng; Shizhi He; Hongzhi Ma; Lizhen Hou; Meng Lian; Qian Shi; Xixi Shen; Yifan Yang; Ru Wang
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

Review 8.  Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge.

Authors:  Zhouying Peng; Yumin Wang; Ruohao Fan; Kelei Gao; Shumin Xie; Fengjun Wang; Junyi Zhang; Hua Zhang; Yuxiang He; Zhihai Xie; Weihong Jiang
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

9.  Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.

Authors:  Tatsanachat Jittreetat; Yoo Seob Shin; Hye Sook Hwang; Bok-Soon Lee; Yeon Soo Kim; Phakdee Sannikorn; Chul-Ho Kim
Journal:  Yonsei Med J       Date:  2016-05       Impact factor: 2.759

10.  Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection.

Authors:  Xiaoyun Li; Chao Lin; Jinjie Yan; Qiuyan Chen; Xuesong Sun; Sailan Liu; Shanshan Guo; Liting Liu; Haojun Xie; Qingnan Tang; Yujing Liang; Ling Guo; Hao Li; Xuekui Liu; Xiang Guo; Linquan Tang; Haiqiang Mai
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.